The vasoactive intestinal peptide (VIP) of parasympathetic origin may contribute to clozapine (muscarinic M1-receptor)-induced sialorrhea, an adverse effect created by its synergistic interaction with the antipsychotic in some patients with schizophrenia (73). This evidence concerns the gene VIP and Drooling.